Fundraising FoxEnterprise Ireland — 2025 Investments
6 investments dated 2025 · listed companies and verified rows first · show all
The Corporate Governance Institute offers an online professional certificate course in company secretary training covering corporate governance, board management, compliance, and ESG practices for governance professionals and board members.
EdTechEnterprise SoftwareGovTechLegalTech
David W Duffy(Co-Founder & Chairman)inFintan Finnan(Chief Revenue Officer (CRO))in
Co-investorsBusiness Venture PartnersBessemer Venture Partners
Orreco combines AI with sports science to turn athlete data — including blood biomarkers, menstrual cycle tracking, and injury prediction — into actionable recovery and performance recommendations for elite athletes, pro teams, coaches, and doctors.
AI & Machine LearningDigital HealthSports TechGalway, IE
Dr. Brian Moore(CEO, Sports Scientist; co-founder)Dr. Andrew Hodgson(Clinical Director; co-founder)Professor Charlie Pedlar(Chief Science Officer)Niall Killilea(Chief Operating Officer)in
Co-investorsTrue VenturesComcast Ventures20VC
Output is a Los Angeles-based music-technology company that builds SaaS tools like Arcade, offering musicians and producers loops, samples, and virtual instruments for music creation.
Gregg Lehrman(Founder)in
Co-investorsSummit PartnersApex CapitalUni.Fund
A platform that combines athlete assessment, velocity-based training guidance, and performance data analysis to help strength and conditioning professionals design and manage training programs.
HealthtechSaaSSports Tech
Martin O'Reilly, PhD(Founder)in
Co-investorsAtlantic Bridge VenturesUni.FundApex CapitalElkstone Capital Partners
Qualio provides a compliance platform for life science companies that combines quality management, regulatory intelligence, and AI agents to accelerate product delivery.
AI & Machine LearningBiotechHealthtechSaaSSan Francisco, US
Robert Fenton(Founder)in
BoardVijay Nagappan(Director)inArun Penmetsa(Director)in
Co-investors500 GlobalFrontline VenturesMenlo VenturesStorm VenturesMHS CapitalOperator Partners+2 more
Urotronic develops drug-coated balloons for interventional urology, including the Optilume products for treating benign prostatic hyperplasia (BPH) and urethral strictures.
HealthtechMedical DevicesPlymouth, US
Junfeng Wang(Director)David Perry(Executive Officer, Director)Tan Ching(Director)Hui Hu(Director, Promoter)Lixiao Wang(Director, Promoter)Doug Kohrs(Director)
Co-investorsHM Venture PartnersGilde HealthcareIreland Strategic Investment FundLegend CapitalLightstone VenturesMVM Life Science Partners+1 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.